- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04635345
Feasibility of Use of Vibrators With Vaginal Dilators for Vaginismus. (Vibrator Therapy and Dilators in Vaginismus) (ViTaDiVa)
A Pilot Study Assessing the Feasibility of Using Clitoral Vibrators to Aid Vaginal Dilator Therapy in Women Presenting to Psychosexual Services With Vaginismus.
The acceptability of vulvar vibration therapy has been evaluated in women with vulvodynia, and found to be acceptable, however has not been assessed in women with a primary complaint of vaginismus.
This proposed study looks at the feasibility and acceptability of using clitoral vibration therapy, alongside current therapy, for women with vaginismus. It is likely that many, if not most, of these women will also have an element of vulvodynia. The investigators propose that the use of external clitoral or vulval vibration therapy is likely to be acceptable in most women with vaginismus, based on acceptability of vulvar vibration therapy in women with vulvodynia.
It is proposed that vibrator therapy may help women with female sexual dysfunction to use vaginal dilators.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a nonrandomized controlled trial, with the initial cluster of patients receiving standard therapy, and the second cluster receiving standard therapy plus vibrator. Recruitment will be an initial 15 participants who will receive standard therapy, and then another 15 who will receive an external vibrator.
This study will take place over approximately 12 months. Enrollment of patients will be from a joint psychosexual clinic led by a medical doctor and a clinical psychologist. Female patients are referred to this clinic by General Practitioners, from within the Sexual Health service, or via Gynaecologists, frequently with complaint of difficulty or pain with penetrative sex. Exclusion criteria will be: patients unable/ unwilling to consent, transgender male or on testosterone therapy, unable to understand written and/or verbal English, current dermtatological skin conditions requiring active treatment, genital herpes simplex virus within 3 months, or not reporting symptoms of vaginismus with no evidence of vaginismus on clinical examination.
Trial information will be given at the initial appointment. If the patient wishes to enrol, than an initial baseline questionnaire will be given, and a follow up questionnaire will be filled out by phone contact at 3-4 months afterward the initial consultation at the patients consent.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jessica Gaddie, MbCHb, BSc
- Phone Number: 0207 377 7315
- Email: j.gaddie1@nhs.net
Study Contact Backup
- Name: Jill Zelin
- Email: jill.zelin@nhs.net
Study Locations
-
-
-
London, United Kingdom, E1 2BB
- Recruiting
- Ambrose King Sexual Health Centre
-
Contact:
- Jessica Gaddie, MBChB
- Email: j.gaddie1@nhs.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Able and willing to give informed consent (additional measures have to be in place if children, vulnerable adults or adults unable to give consent are included)
- Female
- Over the age of 18
- With symptoms and clinical signs consistent with vaginismus/ vaginismus and vulvodynia.
Exclusion Criteria:
- Unwilling or unable to give consent
- Transgender male / on testosterone therapy
- Inability to understand written and / or verbal English
- Current dermatological skin conditions requiring active treatment
- Genital herpes simplex virus symptoms within preceding 3 months
- Not reporting symptoms of vaginismus, and no evidence of vaginismus on clinical examination.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vibrator Therapy + dilator/standard therapy
Patient will receive standard therapy (initial appointment, referral for womens health physiotherapy or psychosexual counselling as standard, together with vadinal dilators and lidocaine gel) plus an external vibrator.
|
Patient provided with external vibrator for self-use, as well as vaginal dilators.
Dilators, lidocaine topical gel, referral to psychotherapy, group therapy or womens health physio if required, self-help resources.
|
Active Comparator: Dilator/standard therapy
Patient will receive standard therapy (initial appointment, referral for womens health physiotherapy or psychosexual counselling as standard, together with vadinal dilators and lidocaine gel).
|
Dilators, lidocaine topical gel, referral to psychotherapy, group therapy or womens health physio if required, self-help resources.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Is vibration therapy (through the use of handheld external vibrators on clitoral and vulval area) acceptable to women as part of medical management of vaginismus and vaginismus/vulvodynia, alongside current medical management?
Time Frame: 12-18 months
|
Qualitative questionnaire
|
12-18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Does the use of clitoral/ vulval vibrators help women to progress more easily with the use of vaginal dilators compared to women not using these?
Time Frame: 12-24 months
|
Qualitative questionnaire
|
12-24 months
|
Is there any self-reported difference in experiences of pleasure or enjoyment around sexual experiences in the two groups of women as reported by FSDS (Female Sexual Distress Scale) Scores?
Time Frame: 12-24 months
|
Questionnaire - FSDS (above)
|
12-24 months
|
Is there any self-reported difference in experiences of pleasure or enjoyment around sexual experiences in the two groups of women as reported by FSFI (Female Sexual Function Index) Scores?
Time Frame: 12-24 months
|
Questionnaire - FSFI (above)
|
12-24 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jess Gaddie, Barts & The London NHS Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 278027
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginismus
-
Karachi Medical and Dental CollegeAziz Medical CenterCompleted
-
Tehran University of Medical SciencesUnknown
-
Bezmialem Vakif UniversityRecruiting
-
Sheba Medical CenterCompletedErectile Dysfunction | Hypoactive Sexual Desire Disorder | Dyspareunia | Vaginismus
-
Abdel-Maguid RamzyCompleted
-
Hillel Yaffe Medical CenterThe Baruch Padeh Medical Center, PoriyaUnknownDepression | Child Abuse | Dystocia | VaginismusIsrael
-
Plastic Surgery Professional AssociationAllerganCompleted
-
Imperial College LondonNorwegian University of Science and Technology; KU Leuven; Imperial College Healthcare... and other collaboratorsCompletedVaginismus | Placenta PraeviaUnited Kingdom
-
Dr. John A. Thiel Medical Professional CorporationUnknownPelvic Floor Dyssynergia
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedMuscle Tone Poor | Vaginismus | Sexual Dysfunctions | Muscular HypertonicityBrazil
Clinical Trials on External Vibrator - patient-administered.
-
Samsun Education and Research HospitalCompleted
-
Gazi UniversityCompletedEvaluating the Validity and Reliability of the Turkish WOOSTurkey
-
National Taiwan University HospitalNot yet recruitingPerioeprative Muscle Loss
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance AbuseUnited States
-
Duke UniversityCompletedHip Pain Chronic | Hip DiseaseUnited States
-
University of LeedsUniversity of Nottingham; World Health Organization; The Regional Government...CompletedTuberculosis, Pulmonary | Quality of Health Care | Community Health Care | Volunteer Health Workers | Tuberculosis Treatment EffectivenessEthiopia
-
Yale UniversityAstraZenecaCompletedHeart Failure With Reduced Ejection FractionUnited States
-
Yale UniversityAstraZenecaCompletedHeart FailureUnited States
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece